Amino Acid, Peptide, or ProteinDATEImmunologic Factor CatalYm Presents Long-Term Phase 1/2a Data for Visugromab at ESMO 2025 4 days ago talkbio0Tagged CatalYm, CPI-refractory tumors, ESMO, Growth Differentiation Factor 15, Visugromab CatalYm; Visugromab; ESMO 2025; CPI-Refractory Tumors; GDF-15 Read More